10x Genomics Market Sentiment

10x Genomics Inc

TXGNASDAQ

Trade with Public

$63.90

-0.82-1.27%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

10x Genomics Market Sentiment

Market sentiment signals for 10x Genomics (TXG): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▼ 17.9% short float

Options Flow▼ 6.66 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Neutral

20 analysts

Options Flow (P/C)

6.66

More puts — Bearish

79 calls · 526 puts

Avg Consensus PT

$33

-47.9%

Highest Price Target

$65

+1.7%

Stephens & Co.

Lowest Price Target

-89.8%

Goldman Sachs

Short Interest

17.9%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 12, 2026	Stephens & Co.	Mason Carrico—	+1.7%	$50 → $65	Maintained	Overweight
Aug 10, 2026	Piper Sandler	David Westenberg—	-26.4%	$42 → $47	Maintained	Neutral
Aug 10, 2026	Canaccord Genuity	Kyle Mikson—	-6.1%	$50 → $60	Maintained	Buy
Aug 7, 2026	Citigroup	Brendan Digan—	-21.7%	$45 → $50	Maintained	Neutral
Aug 7, 2026	Morgan Stanley	Tejas Savant—	-37.4%	$37 → $40	Maintained	Equal-Weight
Jul 17, 2026	Leerink Partners	Mike Kratky—	-37.4%	$23 → $40	Maintained	Market Perform
Jul 14, 2026	Canaccord Genuity	Kyle Mikson—	-21.7%	$32 → $50	Maintained	Buy
Jul 9, 2026	Morgan Stanley	Tejas Savant—	-42.1%	$22 → $37	Maintained	Equal-Weight
Jul 8, 2026	Citigroup	Patrick Donnelly—	-29.6%	$24 → $45	Maintained	Neutral
Jul 1, 2026	Piper Sandler	David Westenberg—	-34.3%	$20 → $42	Maintained	Neutral
Jun 24, 2026	Barclays	Luke Sergott—	-37.4%	$30 → $40	Maintained	Overweight
May 12, 2026	Morgan Stanley	Tejas Savant—	-65.6%	$20 → $22	Maintained	Equal-Weight
May 12, 2026	JP Morgan	Casey Woodring—	-68.7%	$17 → $20	Maintained	Neutral
Apr 20, 2026	Canaccord Genuity	Kyle Mikson—	-49.9%	$22 → $32	Maintained	Buy
Apr 20, 2026	B of A Securities	Derik De Bruin—	-53.0%	$21 → $30	Maintained	Neutral
Apr 14, 2026	Barclays	Luke Sergott—	-53.0%	$22 → $30	Maintained	Overweight
Apr 7, 2026	Citigroup	Patrick Donnelly—	-62.4%	$18 → $24	Maintained	Neutral
Mar 31, 2026	William Blair	Matt Larew—	—	—	Upgrade	Market Perform→Outperform
Mar 2, 2026	Stifel	Daniel Arias—	-60.9%	$20 → $25	Maintained	Buy
Feb 20, 2026	UBS	Dan Leonard—	-68.7%	$14 → $20	Maintained	Neutral
Feb 13, 2026	Stifel	Daniel Arias—	-68.7%	$15 → $20	Maintained	Buy
Feb 13, 2026	TD Cowen	Dan Brennan—	-70.3%	$18 → $19	Maintained	Hold
Jan 27, 2026	Leerink Partners	Mike Kratky—	-68.7%	$22 → $20	Maintained	Market Perform
Jan 16, 2026	Leerink Partners	Mike Kratky—	-65.6%	$20 → $22	Maintained	Market Perform
Jan 7, 2026	Leerink Partners	Mike Kratky—	-68.7%	$15 → $20	Maintained	Market Perform